Compare VKTX & BELFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VKTX | BELFA |
|---|---|---|
| Founded | 2012 | 1949 |
| Country | United States | United States |
| Employees | N/A | 4964 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.3B |
| IPO Year | 2014 | N/A |
| Metric | VKTX | BELFA |
|---|---|---|
| Price | $34.85 | $232.95 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $95.86 | ★ $174.25 |
| AVG Volume (30 Days) | ★ 2.4M | 178.2K |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.10% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.74 |
| Revenue Next Year | N/A | $6.34 |
| P/E Ratio | ★ N/A | $40.02 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.96 | $105.98 |
| 52 Week High | $43.15 | $293.51 |
| Indicator | VKTX | BELFA |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 46.35 |
| Support Level | $34.03 | $213.40 |
| Resistance Level | $36.77 | $275.55 |
| Average True Range (ATR) | 2.05 | 11.25 |
| MACD | -0.66 | 0.63 |
| Stochastic Oscillator | 3.75 | 63.55 |
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.